Clinical Trial: Central Serous Chorioretinopathy: Etiology, Course and Prognosis

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Central Serous Chorioretinopathy: An Observational Study About Etiology, Course and Prognosis

Brief Summary: Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.

Detailed Summary: Patients with central serous chorioretinopathy are recruited from the Department of Ophthalmology at the Medical University of Vienna. All patients undergo ETDRS visual acuity measurement, Pelli-Robson contrast examination, Amsler-Grid testing, questionnaire testing, ophthalmologic examination, SD-OCT and polarization-sensitive OCT, fundus autofluorescence, fluorescein angiography, indocyanine-green angiography, fundus photo and microperimetry. Patients are re-examined after an interval of 6 weeks until subretinal fluid is entirely reabsorbed to gain further insides in etiology, course and prognosis of this disease.
Sponsor: Medical University of Vienna

Current Primary Outcome: Clinical Outcome [ Time Frame: 2 years ]

OCT, Visus


Original Primary Outcome:

Current Secondary Outcome: Subclinical Data [ Time Frame: 2 years ]

FA findings, retinal sensitivity in Microperimetry, contrast sensitivity, Amsler Grid Test


Original Secondary Outcome:

Information By: Medical University of Vienna

Dates:
Date Received: June 20, 2011
Date Started: April 2011
Date Completion:
Last Updated: April 25, 2013
Last Verified: April 2013